Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

300

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

300 results for “infliximab”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov28/100

The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol

ClinicalTrials.gov study NCT00246064. IPD Sharing: Not stated. Countries: 0. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Personalized Infliximab Induction Strategy With Model-informed Dosing in Patients With Crohn's Disease

ClinicalTrials.gov study NCT04974099. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
geo24/100

mRNA expression profile in peripheral blood cells of RA patients following treatment with an anti-TNFa mAb, infliximab

GEO Series GSE8350. Homo sapiens. 72 samples. Type: Expression profiling by array.

openGEO-OpenOct 2007View details →
geo24/100

Microarray predictor of response to infliximab in rheumatoid arthritis (RA) patients

GEO Series GSE12051. Homo sapiens. 44 samples. Type: Expression profiling by array.

openGEO-OpenOct 2009View details →
zenodo24/100

Evaluation of selected serum biomarkers levels in response to infliximab reference product (Remicade®) versus it's biosimilar (Remsima®) in a sample of ulcerative colitis patients: a cross-sectional study

<p><strong>Evaluation of selected serum biomarkers levels in response to infliximab reference product (Remicade</strong><sup>&reg;</sup><strong>) versus it&#39;s biosimilar (Remsima</strong><sup>&reg;</sup><strong>) in a sample of ulcerative colitis patients: a cross-sectional&nbsp;study</strong></p>

opencc-by-4.0Jul 2023View details →
ClinicalTrials.gov24/100

Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)

ClinicalTrials.gov study NCT00695682. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease

ClinicalTrials.gov study NCT02453607. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis

ClinicalTrials.gov study NCT01408810. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease

ClinicalTrials.gov study NCT00228839. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

CT-P13 (Infliximab) Subcutaneous Administration by Pre-filled Syringe and Auto-injector in Healthy Subjects

ClinicalTrials.gov study NCT03446976. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

Metabolic Response to Infliximab in Pediatric Ulcerative Colitis

ClinicalTrials.gov study NCT00586807. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Photographic Library of Moderate to Severe Psoriasis Subjects Treated With Infliximab (Study P05047)

ClinicalTrials.gov study NCT00749398. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).

ClinicalTrials.gov study NCT00380796. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612)

ClinicalTrials.gov study NCT00687401. IPD Sharing: YES. Countries: 0. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov24/100

Dose Optimization of Infliximab in Moderate to Severe Plaque Psoriasis (Study P05315)

ClinicalTrials.gov study NCT00833053. IPD Sharing: YES. Countries: 0. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov24/100

Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy

ClinicalTrials.gov study NCT01299545. IPD Sharing: Not stated. Countries: 8. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Infliximab to Treat Children With Juvenile Rheumatoid Arthritis

ClinicalTrials.gov study NCT00029042. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Infliximab and Classic DMARDs in the Rheumatoid Arthritis Patients

ClinicalTrials.gov study NCT01915537. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis

ClinicalTrials.gov study NCT00216177. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement

ClinicalTrials.gov study NCT02293681. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record